Showing results (521-530 of 6,290) with videos related to
Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|March 30, 2007
Impact of obesity on coronary artery calcification examined by electron beam computed tomographic scanC-H Hsu, S G N Chang, K-C Hwang, et al.Diabetes, Obesity & Metabolism|April 11, 2007
National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli studyE Mannucci, M Monami, B Cresci, et al.Diabetes, Obesity & Metabolism|July 17, 2008
Beyond insulin replacement: addressing the additional needs of the diabetes patientG DaileyDiabetes, Obesity & Metabolism|June 20, 2008
Current treatment of non-alcoholic fatty liver diseaseMohamed H Ahmed, Christopher D ByrneDiabetes, Obesity & Metabolism|June 20, 2008
Risk factor assessment for new onset diabetes: literature reviewGeorge Bakris, Jack Stockert, Mark Molitch, et al.Diabetes, Obesity & Metabolism|June 20, 2008
Excess glycaemic excursions after an oral glucose tolerance test compared with a mixed meal challenge and self-measured home glucose profiles: is the OGTT a valid predictor of postprandial hyperglycaemia and vice versa?J J Meier, B Baller, B A Menge, et al.Diabetes, Obesity & Metabolism|November 1, 2007
Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverseC L Oltman, E P Davidson, L J Coppey, et al.Diabetes, Obesity & Metabolism|November 1, 2007
Effects of combined PPARgamma and PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty ratJ Tanabe, N Tamasawa, M Yamashita, et al.Diabetes, Obesity & Metabolism|October 10, 2006
Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMIG Biesenbach, A Raml, N AlsarajiDiabetes, Obesity & Metabolism|June 3, 2004
Intramyocellular lipids and insulin resistanceJürgen Machann, Hans Häring, Fritz Schick, et al.Pageof 629